Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)
Frans van der Kloet(University of Amsterdam), Thomas Hankemeier(Centre for Human Drug Research), Carol Forsblom(University of Helsinki), Per‐Henrik Groop(University of Helsinki), Gerwin Spijksma, Ville‐Petteri Mäkinen(Helsinki University Hospital), F. W. Alexander Tempels, J. van der Greef(Leiden University), Piotr T. Kasper(Netherlands Metabolomics Centre), Miguel Rojas‐Chertó(Netherlands Metabolomics Centre), Ronnie van Doorn(Netherlands Metabolomics Centre), Maud M. Koek(Pension Fund for Care and Well-Being), Nurlaila Ismail, Harry Holthöfer(University of Helsinki), Robert van der Heijden, Theo Reijmers(Netherlands Metabolomics Centre)
Cited by 163
Related Papers
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome
|Alzheimer s & Dementia|2018|690
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
|Diabetes|2009|641
Metabolomics enables precision medicine: “A White Paper, Community Perspective”
|Metabolomics|2016|615
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2013|578